Cleveland Clinic’s Medical Innovation Summit will bring together more than 2,250 of the brightest leaders from around the world to downtown Cleveland on October 23-25, 2017, to discuss transformative technologies that will deliver on the powerful promise of genomics and precision medicine.
“Genomics and precision medicine are transforming the care we provide our patients and are on the brink of revolutionizing all aspects of the healthcare delivery system,” said Brian Donley, M.D., Chief of Staff at Cleveland Clinic. “The Medical Innovation Summit brings together some of the world’s most renowned business and thought leaders with the goal of furthering this progress, moving new ideas into market and ultimately improving the daily lives of patients.”
Now in its 15th year, the annual Medical Innovation Summit is organized by Cleveland Clinic Innovations, the development and commercialization arm of Cleveland Clinic, which has developed 77 spin-off companies since it was founded in 2000.
The agenda includes thought-provoking panels, as well as lively 1-on-1 discussions with top healthcare, industry and biotech leaders. Topics include: next-generation genomic sequencing; the gene therapy and gene editing markets; artificial intelligence and decision support technologies; customized implants and robotics; the investors’ perspective on precision medicine; and reimbursement strategies for genomic innovation.
“Genomics and precision medicine may hold the key to managing and eliminating some of the most debilitating diseases,” said Peter O’Neill, executive director of Cleveland Clinic Innovations. “We see a lot of activity in this market area, and we’re looking forward to this year’s Medical Innovation Summit and advancing the conversation about innovation in this exciting space.”
The 2017 Medical Innovation Summit will be held at the Huntington Convention Center in downtown Cleveland. Registration is now open.